CureVac N.V. (CVAC)
NASDAQ: CVAC · IEX Real-Time Price · USD
3.340
+0.010 (0.30%)
At close: Jul 2, 2024, 4:00 PM
3.260
-0.080 (-2.40%)
After-hours: Jul 2, 2024, 7:57 PM EDT

CureVac Revenue

CureVac had revenue of $64.13M in the twelve months ending March 31, 2024, with 17.59% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $13.45M with 73.56% year-over-year growth. In the year 2023, CureVac had annual revenue of $59.73M, a decrease of -16.72%.

Revenue (ttm)
$64.13M
Revenue Growth
+17.59%
P/S Ratio
11.68
Revenue / Employee
$64,197
Employees
999
Market Cap
749.18M USD

Revenue Chart

* The company reports in EUR currency but revenue data is shown in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202359.73M-11.99M-16.72%
Dec 31, 202271.72M-45.31M-38.72%
Dec 31, 2021117.03M57.44M96.37%
Dec 31, 202059.60M40.03M204.56%
Dec 31, 201919.57M4.77M32.27%
Dec 31, 201814.79M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Healthcare Services Group 1.68B
CareDx 275.11M
Ginkgo Bioworks Holdings 208.70M
Atrion 176.67M
Harrow Health 138.68M
Dianthus Therapeutics 2.26M
Revenue Rankings